| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy
|
Löscher, Wolfgang
|
|
2002
|
50 |
1-2 |
p. 105-123
19 p.
|
artikel
|
| 2 |
Antiepileptic drugs in psychiatry—focus on randomized controlled trial
|
Muzina, David J
|
|
2002
|
50 |
1-2 |
p. 195-202
8 p.
|
artikel
|
| 3 |
Antiepileptic drugs to prevent neural degeneration associated with epilepsy: assessing the prospects for neuroprotection
|
Sutula, Thomas
|
|
2002
|
50 |
1-2 |
p. 125-129
5 p.
|
artikel
|
| 4 |
Critical re-evaluation of previous preclinical strategies for the discovery and the development of new antiepileptic drugs
|
Löscher, W
|
|
2002
|
50 |
1-2 |
p. 17-20
4 p.
|
artikel
|
| 5 |
Current evidence indicates that antiepileptic drugs are anti-ictal, not antiepileptic
|
Schachter, Steven C
|
|
2002
|
50 |
1-2 |
p. 67-70
4 p.
|
artikel
|
| 6 |
Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs
|
Meldrum, Brian
|
|
2002
|
50 |
1-2 |
p. 33-40
8 p.
|
artikel
|
| 7 |
Do the epilepsies, pain syndromes, and affective disorders share common kindling-like mechanisms?
|
Post, Robert M
|
|
2002
|
50 |
1-2 |
p. 203-219
17 p.
|
artikel
|
| 8 |
Efficacy of current antiepileptics to prevent neurodegeneration in epilepsy models
|
Pitkänen, Asla
|
|
2002
|
50 |
1-2 |
p. 141-160
20 p.
|
artikel
|
| 9 |
Evaluation and prediction of effects of antiepileptic drugs in a variety of other CNS disorders
|
Lopes da Silva, Fernando
|
|
2002
|
50 |
1-2 |
p. 191-193
3 p.
|
artikel
|
| 10 |
Kindling: some old and some new
|
McIntyre, Dan C
|
|
2002
|
50 |
1-2 |
p. 79-92
14 p.
|
artikel
|
| 11 |
Memory impairment in temporal lobe epilepsy: the role of entorhinal lesions
|
Schwarcz, Robert
|
|
2002
|
50 |
1-2 |
p. 161-177
17 p.
|
artikel
|
| 12 |
Neuroimaging methods to evaluate the etiology and consequences of epilepsy
|
Duncan, John S
|
|
2002
|
50 |
1-2 |
p. 131-140
10 p.
|
artikel
|
| 13 |
New horizons in the development of antiepileptic drugs
|
Löscher, Wolfgang
|
|
2002
|
50 |
1-2 |
p. 3-16
14 p.
|
artikel
|
| 14 |
New insights from the use of pilocarpine and kainate models
|
Leite, J.P
|
|
2002
|
50 |
1-2 |
p. 93-103
11 p.
|
artikel
|
| 15 |
New strategies for the identification of drugs to prevent the development or progression of epilepsy
|
Schmidt, Dieter
|
|
2002
|
50 |
1-2 |
p. 71-78
8 p.
|
artikel
|
| 16 |
[No title]
|
Löscher, Wolfgang
|
|
2002
|
50 |
1-2 |
p. 1-
1 p.
|
artikel
|
| 17 |
The clinical impact of new antiepileptic drugs after a decade of use in epilepsy
|
Schmidt, Dieter
|
|
2002
|
50 |
1-2 |
p. 21-32
12 p.
|
artikel
|
| 18 |
The interface of preclinical evaluation with clinical testing of antiepileptic drugs: role of pharmacogenomics and pharmacogenetics
|
Holmes, Gregory L.
|
|
2002
|
50 |
1-2 |
p. 41-54
14 p.
|
artikel
|
| 19 |
The role of seizure-induced neurogenesis in epileptogenesis and brain repair
|
Parent, Jack M
|
|
2002
|
50 |
1-2 |
p. 179-189
11 p.
|
artikel
|
| 20 |
Use of epileptic animals for adverse effect testing
|
Klitgaard, Henrik
|
|
2002
|
50 |
1-2 |
p. 55-65
11 p.
|
artikel
|
Tijdschrift beschrijving